[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
October 1965

Clinical Testing of New Drugs.

Arch Intern Med. 1965;116(4):628-629. doi:10.1001/archinte.1965.03870040142039

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Clinical pharmacology is one of the newest and most rapidly growing academic disciplines in medical schools in this country in the last ten years. The modern clinical pharmacologist has many interests. His work is concerned with drug metabolism, mechanism of action of drugs, efficacy and safety of agents given to man, and fundamental studies in which he may use drugs to shed light on the causes of various disease states. He may plan and carry out controlled clinical trials of new drugs in man. Several books have been written on this latter subject in the last few years. Herrick and Cattell have gathered together several papers, most of which have already been published "in somewhat different form" in The Journal of New Drugs, and added several articles written by members of the Food and Drug Administration, as well as copies of the pertinent new drug regulations and forms.

The list

First Page Preview View Large
First page PDF preview
First page PDF preview